ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.498,38
0,32%
S&P 500
5.187,67
0,00%
Dow Jones
39.056,39
0,44%
Euro vs US Dollar
1,0747
0,00%
Bitcoin
61.475,99
0,47%
Registration Strip Icon for charts Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Alaunos Therapeutics Inc (TCRT)

  7. Alaunos Therapeutics Inc (TCRT) News

TCRT

Alaunos Therapeutics (TCRT)

Alaunos Therapeutics Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:TCRT
DatumZeitQuelleÜberschriftSymbolFirma
29/02/202403h46Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:TCRTAlaunos Therapeutics Inc
22/02/202422h44Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TCRTAlaunos Therapeutics Inc
20/02/202422h05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TCRTAlaunos Therapeutics Inc
14/02/202418h43Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:TCRTAlaunos Therapeutics Inc
13/02/202422h58Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:TCRTAlaunos Therapeutics Inc
29/01/202414h45Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TCRTAlaunos Therapeutics Inc
23/01/202423h47Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TCRTAlaunos Therapeutics Inc
22/01/202422h30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TCRTAlaunos Therapeutics Inc
03/01/202423h30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TCRTAlaunos Therapeutics Inc
03/01/202423h25Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:TCRTAlaunos Therapeutics Inc
02/01/202414h00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TCRTAlaunos Therapeutics Inc
28/12/202322h30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TCRTAlaunos Therapeutics Inc
22/12/202314h00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TCRTAlaunos Therapeutics Inc
15/11/202313h30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TCRTAlaunos Therapeutics Inc
14/11/202313h30GlobeNewswire Inc.Alaunos Therapeutics Announces Third Quarter 2023 Financial Results, Phase 1 Clinical Data and Continued Exploration of Strategic AlternativesNASDAQ:TCRTAlaunos Therapeutics Inc
28/09/202322h01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TCRTAlaunos Therapeutics Inc
05/09/202323h34Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TCRTAlaunos Therapeutics Inc
01/09/202318h20Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:TCRTAlaunos Therapeutics Inc
14/08/202322h37Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:TCRTAlaunos Therapeutics Inc
14/08/202322h16Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TCRTAlaunos Therapeutics Inc
14/08/202322h05GlobeNewswire Inc.Alaunos Therapeutics Announces Second Quarter 2023 Financial Results, Interim Clinical Data and Exploration of Strategic AlternativesNASDAQ:TCRTAlaunos Therapeutics Inc
29/06/202313h00GlobeNewswire Inc.Alaunos Therapeutics Announces Presentation at the 2nd Hawaii Global Summit on Thoracic MalignanciesNASDAQ:TCRTAlaunos Therapeutics Inc
12/06/202322h16Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:TCRTAlaunos Therapeutics Inc
08/06/202323h25Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:TCRTAlaunos Therapeutics Inc
08/06/202323h24Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:TCRTAlaunos Therapeutics Inc
25/05/202323h00GlobeNewswire Inc.Alaunos Therapeutics to Present Early Data from TCR-T Library Phase 1/2 Trial at 2023 American Society of Clinical Oncology Annual MeetingNASDAQ:TCRTAlaunos Therapeutics Inc
10/05/202313h32Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:TCRTAlaunos Therapeutics Inc
10/05/202313h00GlobeNewswire Inc.Alaunos Therapeutics Reports First Quarter 2023 Financial ResultsNASDAQ:TCRTAlaunos Therapeutics Inc
03/05/202314h30GlobeNewswire Inc.Alaunos Therapeutics to Report First Quarter 2023 Financial Results on May 10, 2023NASDAQ:TCRTAlaunos Therapeutics Inc
26/04/202318h30GlobeNewswire Inc.Alaunos Therapeutics Announces Poster Presentation at the American Society of Clinical Oncology (ASCO) 2023 Annual MeetingNASDAQ:TCRTAlaunos Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:TCRT

Kürzlich von Ihnen besucht

NYSE
KO
Coca Cola
TG
ALV
Allianz
COIN
ETHUSD
Ethereum
FX
EURJPY
Euro vs Yen
TG
BAS
BASF
TG
BAYN
Bayer
NYSE
JPM
JP Morgan Chase
DBI
DAX
DAX
COIN
BTCUSD
Bitcoin
AMEX
XLF
Financial Select Sector
NASDAQ
TSLA
Tesla
TG
432
Arbor Metals
TG
NOV
Novo Nordisk
TG
MBG
MercedesBenz
NYSE
MRK
Merck
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten